Research, stories, and advocacy.
A survey from the Global Colon Cancer Association examines biomarker testing awareness, access, and utilization among Japanese American patients, revealing critical gaps and opportunities for more equitable precision care.
Cheri shares her CRC experience from asymptomatic screening to treatment of Stage IV colorectal cancer.
HER2 is a biomarker that is important in colorectal cancer. While HER2 is best known for its role in breast cancer, it can also play an important role in colorectal cancer. Understanding HER2 starts with a key concept in cancer biology: oncogenes.
The Global Colon Cancer Association, FUTEJE, and From Testing to Targeted Treatment Launch New Collaboration During Colorectal Cancer Awareness Month
The Global Colon Cancer Association officially launched the Knowing Is Worth the Wait campaign at ASCO GI, bringing biomarker awareness to oncologists and patient advocates from 40 countries.
Over the last several months, the Global Colon Cancer Association has presented a patient education campaign on Tumor Sidedness as part of our Know Your Biomarker program. Here are the key takeaways.
Troy's life was saved by biomarker testing.
Genetic testing changed Dan's life, leading to more than 13 years cancer free.
